In the AD rat model, the intervention of MEG3 improves cognitive impairment, alleviates neuronal damage and inhibits astrocyte activation in hippocampus tissues in AD by inactivating the PI3K/Akt signaling pathway. This evidence concerns the gene MEG3 and Alzheimer disease.